Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Milwaukee › NPI 1871656082
Hospital

Columbia ST. Mary's Hospital Milwaukee, INC.

Columbia ST. Mary's Hospital Milwaukee, INC. was paid $64.53M by Medicaid between Jan 2018 and Dec 2024, across 597 billing codes. Its largest line is 99283, emergency room visit (moderate) — 7.5% of everything it billed.

33Billing provider infoCOLUMBIA ST. MARY'S HOSPITAL MILWAUKEE, INC.
MILWAUKEE, WI 53211
33aNPI1871656082assigned 12/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$64.53M
24GClaims3,044,285
24DCodes billed597
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#4 of 60
Median peer was paid$2.90M
This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018499,671$10.45M
2019474,096$9.29M
2020373,832$8.17M
2021434,948$8.65M
2022412,142$9.04M
2023498,615$10.68M
2024incomplete350,981$8.26M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.5% 78,459 66,775 $4.83M
96361 Intravenous infusion, hydration; each additional hour 6.8% 35,911 27,332 $4.41M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.6% 67,880 56,652 $3.61M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3.6% 50,009 40,140 $2.30M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.4% 43,585 35,501 $2.21M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.2% 43,707 35,236 $2.04M
80053 Comprehensive metabolic panel 3.1% 104,099 78,837 $1.98M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.9% 23,780 19,726 $1.90M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.0% 38,589 30,170 $1.29M
80048 Basic metabolic panel (calcium, ionized) 1.7% 57,642 42,240 $1.12M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 16,989 14,512 $1.12M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.7% 38,607 30,221 $1.11M
585 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 133,583 $1.08M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.6% 13,703 $1.01M
70450 Computed tomography, head or brain; without contrast material 1.5% 14,583 $977K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.5% 18,536 $957K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 12,883 $941K
99214 Doctor's office visit, returning patient (more involved) 1.4% 32,854 $890K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.4% 20,054 $885K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.3% 31,384 $837K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 11,737 $776K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.1% 11,245 $714K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.0% 15,360 $664K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 8,083 $640K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 31,294 $638K
59025 Fetal non-stress test <1% 7,644 $588K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 3,225 $531K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 5,299 $518K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 5,419 $517K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,051 $462K
J9271 Injection, pembrolizumab, 1 mg <1% 359 $453K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 6,358 $449K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 12,518 $444K
87081 <1% 17,163 $430K
90853 Group psychotherapy (other than of a multiple-family group) <1% 12,078 $413K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 10,606 $401K
80061 Lipid panel <1% 31,963 $387K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 53,793 $382K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 2,366 $382K
96367 <1% 5,966 $378K
87086 Culture, bacterial; quantitative colony count, urine <1% 27,844 $356K
81025 <1% 38,591 $341K
82962 <1% 28,597 $336K
84443 Thyroid stimulating hormone (TSH) <1% 30,868 $324K
76801 <1% 7,989 $318K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 4,890 $311K
71275 Computed tomographic angiography, chest, with contrast material <1% 3,994 $295K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,801 $290K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 7,778 $285K
84484 <1% 31,825 $283K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 1,997 $279K
87634 <1% 5,180 $276K
83880 <1% 12,305 $267K
D1206 Topical application of fluoride varnish <1% 22,303 $265K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 14,579 $262K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 17,324 $261K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 4,213 $260K
D1351 Sealant - per tooth <1% 17,249 $255K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 11,390 $249K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,291 $237K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 10,567 $228K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 999 $220K
83036 Hemoglobin; glycosylated (A1C) <1% 33,007 $210K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 821 $205K
84702 <1% 9,614 $198K
76830 Ultrasound, transvaginal <1% 5,085 $198K
81001 <1% 41,828 $193K
93356 <1% 2,361 $192K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 8,851 $186K
D0191 <1% 18,861 $178K
99215 Doctor's office visit, returning patient (complex) <1% 4,602 $177K
G0378 Hospital observation service, per hour <1% 11,424 $177K
P9016 Red blood cells, leukocytes reduced, each unit <1% 686 $169K
85027 <1% 29,956 $168K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 430 $163K
96415 <1% 1,973 $152K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,100 $150K
83690 <1% 27,101 $148K
85610 <1% 20,731 $148K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 5,821 $146K
87077 <1% 11,267 $146K
S9480 Intensive outpatient psychiatric services, per diem <1% 2,989 $139K
76642 <1% 3,732 $137K
80081 <1% 2,028 $135K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,647 $134K
86901 <1% 11,058 $134K
12001 <1% 1,608 $133K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 8,557 $132K
72125 Computed tomography, cervical spine; without contrast material <1% 4,186 $130K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,577 $130K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,351 $129K
82728 <1% 8,907 $129K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 6,466 $126K
86850 <1% 8,394 $126K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 2,541 $123K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,048 $120K
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education <1% 2,713 $117K
86780 <1% 12,308 $117K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,335 $115K
76819 Fetal biophysical profile; without non-stress testing <1% 7,000 $115K
71046 Radiologic examination, chest; 2 views <1% 16,670 $113K
87070 <1% 7,273 $112K
86481 <1% 1,571 $108K
86803 <1% 10,216 $106K
97162 <1% 4,384 $104K
70496 <1% 1,388 $97K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 3,153 $96K
71250 <1% 3,117 $95K
70498 <1% 1,430 $93K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,830 $93K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 8,132 $93K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,981 $91K
90791 Psychiatric diagnostic evaluation <1% 2,588 $90K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 570 $88K
87210 <1% 8,361 $87K
93971 <1% 2,686 $83K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,312 $82K
83735 <1% 20,741 $82K
78815 Positron emission tomography (PET) for limited area imaging <1% 547 $82K
93017 <1% 2,256 $82K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 24,023 $82K
82565 <1% 6,352 $79K
82607 <1% 6,794 $79K
93970 <1% 1,942 $78K
12011 <1% 898 $77K
84153 <1% 4,510 $75K
80076 <1% 7,165 $74K
83605 <1% 9,366 $74K
81003 <1% 22,342 $72K
70486 <1% 2,103 $72K
90834 Psychotherapy session, about 45 minutes <1% 2,971 $72K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,181 $71K
80047 <1% 1,570 $70K
80143 <1% 4,083 $65K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 5,972 $64K
D1120 Dental cleaning, child <1% 3,172 $63K
87186 <1% 9,320 $61K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,125 $60K
10060 <1% 804 $56K
90837 Psychotherapy session, about an hour <1% 2,023 $55K
84439 <1% 6,708 $52K
77066 Tomosynthesis, mammo <1% 2,064 $51K
85379 <1% 6,729 $51K
87340 <1% 6,317 $51K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,099 $50K
94060 <1% 1,578 $49K
85007 <1% 13,848 $48K
82950 <1% 3,977 $47K
80050 General health panel <1% 2,043 $45K
97803 <1% 4,585 $44K
83970 <1% 1,803 $43K
87040 <1% 3,949 $43K
80179 <1% 3,968 $42K
73630 <1% 6,325 $42K
86480 <1% 717 $41K
D2150 Silver amalgam - two surfaces, primary or permanent <1% 970 $41K
82746 <1% 4,405 $40K
96417 <1% 1,002 $40K
83655 <1% 3,655 $39K
87147 <1% 6,963 $38K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 12,345 $38K
83615 <1% 7,577 $38K
86762 <1% 3,052 $38K
77336 <1% 1,723 $37K
36430 <1% 523 $37K
12002 <1% 451 $37K
70491 <1% 565 $36K
97163 <1% 1,142 $36K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 52,403 $35K
97161 <1% 1,753 $35K
29581 <1% 753 $35K
83550 <1% 6,348 $34K
76770 <1% 844 $34K
76536 <1% 946 $34K
90715 <1% 4,999 $34K
82570 <1% 7,887 $34K
D0150 Comprehensive oral evaluation - new or established patient <1% 1,701 $33K
87653 <1% 1,269 $33K
87522 Neg quan hep c or qual rna <1% 993 $33K
74018 <1% 3,568 $32K
86900 <1% 11,055 $32K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 850 $31K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,194 $30K
86592 <1% 2,025 $30K
83540 <1% 6,848 $29K
19083 <1% 116 $29K
82043 <1% 6,298 $28K
H0005 Alcohol and/or drug services; group counseling by a clinician <1% 1,089 $28K
77065 Tomosynthesis, mammo <1% 1,459 $28K
86140 <1% 6,026 $27K
99203 Doctor's office visit, new patient (routine) <1% 1,208 $26K
96523 <1% 1,003 $25K
84550 <1% 5,903 $25K
97802 <1% 2,260 $25K
82550 <1% 4,617 $25K
97116 <1% 2,648 $24K
J2323 Injection, natalizumab, 1 mg <1% 48 $24K
77062 <1% 1,566 $23K
84145 <1% 1,540 $22K
84156 <1% 2,984 $22K
85652 <1% 5,257 $21K
86706 <1% 2,528 $21K
85014 <1% 3,966 $21K
94729 <1% 1,890 $21K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 44,303 $21K
84703 <1% 1,980 $20K
84460 <1% 5,002 $19K
71045 Radiologic examination, chest; single view <1% 33,910 $19K
85730 <1% 4,925 $19K
84132 <1% 2,559 $19K
76820 <1% 2,013 $19K
97166 <1% 944 $18K
87075 <1% 2,959 $18K
87102 <1% 461 $18K
D2140 <1% 554 $18K
73030 <1% 4,557 $18K
84450 <1% 4,443 $18K
93798 <1% 254 $18K
72100 <1% 1,861 $17K
D1110 Prophylaxis - adult <1% 634 $17K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 800 $16K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 624 $16K
83021 <1% 941 $16K
87529 <1% 372 $16K
36591 <1% 2,292 $16K
82784 <1% 1,246 $15K
80074 <1% 433 $15K
82247 <1% 897 $15K
86704 <1% 1,362 $15K
D0240 <1% 1,364 $15K
82800 <1% 1,962 $15K
94726 <1% 1,811 $14K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,977 $14K
Q3014 Telehealth originating site facility fee <1% 2,428 $14K
11721 <1% 4,070 $14K
97035 <1% 1,859 $14K
84100 <1% 4,664 $14K
83516 <1% 860 $13K
D0210 Intraoral - complete series of radiographic images <1% 317 $13K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 51 $13K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 654 $13K
99000 <1% 4,219 $13K
82010 <1% 2,082 $12K
85046 <1% 2,797 $12K
87205 <1% 4,036 $12K
73610 <1% 4,254 $12K
86235 <1% 226 $12K
73502 <1% 2,726 $12K
93296 <1% 428 $12K
84481 <1% 1,040 $12K
73564 <1% 5,087 $12K
84403 <1% 571 $11K
88307 <1% 1,070 $11K
80164 <1% 764 $11K
72141 <1% 209 $11K
94660 <1% 146 $11K
D0272 Bitewings - two radiographic images <1% 873 $11K
86003 <1% 173 $11K
0240U <1% 318 $10K
73130 <1% 3,973 $10K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 425 $10K
36415 Collection of venous blood by venipuncture <1% 129,343 $10K
72110 <1% 2,223 $10K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 6,766 $10K
D7140 Extraction, erupted tooth or exposed root <1% 259 $10K
0042T <1% 196 $10K
81511 <1% 96 $10K
71271 <1% 186 $9K
90670 <1% 1,118 $9K
76937 <1% 968 $9K
87631 <1% 86 $9K
85018 <1% 4,229 $9K
73110 <1% 2,165 $9K
86038 <1% 873 $9K
72040 <1% 580 $9K
86923 <1% 606 $9K
J1756 Injection, iron sucrose, 1 mg <1% 2,281 $8K
82248 <1% 2,053 $8K
93308 <1% 80 $8K
83001 <1% 520 $8K
74183 <1% 107 $8K
84160 <1% 749 $8K
73562 <1% 898 $8K
86787 <1% 1,165 $8K
94644 <1% 629 $8K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 137 $7K
96368 <1% 109 $7K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 130 $7K
84165 <1% 1,070 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 30,759 $7K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 209 $7K
93458 <1% 12 $7K
83721 <1% 1,225 $7K
D0140 Limited oral evaluation - problem focused <1% 403 $6K
82378 <1% 768 $6K
97165 <1% 568 $6K
87206 <1% 796 $6K
51702 <1% 381 $6K
80329 <1% 1,874 $6K
86039 <1% 617 $6K
90686 <1% 2,801 $6K
87088 <1% 622 $6K
88342 <1% 3,266 $5K
90723 <1% 724 $5K
83020 <1% 700 $5K
77334 <1% 212 $5K
97535 Self-care/home management training, each 15 minutes <1% 619 $5K
84146 <1% 357 $5K
82803 <1% 316 $5K
73140 <1% 1,507 $5K
81015 <1% 752 $5K
93922 <1% 165 $5K
29125 <1% 205 $5K
76870 <1% 172 $5K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 92 $5K
90651 <1% 141 $5K
D0220 Intraoral - periapical first radiographic image <1% 628 $5K
90680 <1% 413 $4K
11056 <1% 331 $4K
83520 <1% 346 $4K
87045 <1% 159 $4K
99204 Doctor's office visit, new patient (more involved) <1% 666 $4K
20610 <1% 183 $4K
77080 <1% 166 $4K
82947 <1% 1,186 $4K
82105 <1% 199 $4K
86431 <1% 494 $4K
99222 Initial hospital care, per day, moderate complexity <1% 91 $4K
92526 <1% 111 $3K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 137 $3K
H2012 Behavioral health day treatment, per hour <1% 213 $3K
10061 <1% 45 $3K
77061 <1% 300 $3K
H0022 Alcohol and/or drug intervention service (planned facilitation) <1% 150 $3K
77412 <1% 160 $3K
73560 <1% 279 $3K
88304 <1% 1,562 $3K
84520 <1% 1,080 $3K
82652 <1% 173 $3K
74022 <1% 714 $3K
73080 <1% 1,141 $3K
87505 <1% 28 $3K
80177 <1% 203 $3K
71101 <1% 1,421 $3K
82805 <1% 101 $3K
J1453 Injection, fosaprepitant, 1 mg <1% 445 $3K
43235 <1% 18 $2K
87338 <1% 77 $2K
73590 <1% 1,044 $2K
86769 <1% 56 $2K
99232 Hospital visit by a doctor, follow-up day <1% 207 $2K
G0176 Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) <1% 242 $2K
90647 <1% 720 $2K
87807 <1% 230 $2K
D4355 <1% 32 $2K
90792 Psychiatric diagnostic evaluation with medical services <1% 76 $2K
85049 <1% 518 $2K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 205 $2K
98960 <1% 736 $2K
86364 <1% 258 $2K
96156 <1% 113 $2K
96376 <1% 10,906 $2K
97597 <1% 35 $2K
43249 <1% 13 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,291 $2K
98962 <1% 314 $2K
95806 <1% 49 $2K
93246 <1% 110 $2K
D0230 Intraoral - periapical each additional radiographic image <1% 342 $2K
82670 <1% 83 $2K
82330 <1% 161 $2K
87427 <1% 144 $2K
82951 <1% 60 $2K
86225 <1% 144 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 29 $1K
87328 <1% 43 $1K
86430 <1% 301 $1K
90472 Immunization administration, each additional vaccine (list separately) <1% 1,225 $1K
86255 <1% 48 $1K
94002 <1% 22 $1K
90832 Psychotherapy session, about 30 minutes <1% 97 $1K
90633 <1% 389 $1K
77300 <1% 48 $1K
82274 <1% 16 $1K
76942 <1% 22 $1K
73700 <1% 28 $1K
74019 <1% 95 $1K
90674 <1% 451 $1K
72072 <1% 171 $980.48
86593 <1% 131 $964.90
82140 <1% 91 $959.91
82533 <1% 38 $914.28
73660 <1% 92 $886.46
80178 <1% 29 $822.96
0004A <1% 128 $819.52
17110 <1% 22 $812.24
95800 <1% 12 $810.41
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) <1% 190 $807.49
87220 <1% 160 $784.49
87449 <1% 107 $773.48
74174 <1% 13 $714.01
93242 <1% 27 $705.01
99152 <1% 3,515 $699.39
83883 <1% 69 $692.60
88112 <1% 88 $672.63
82164 <1% 15 $661.48
94690 <1% 293 $660.19
86696 <1% 34 $645.98
93880 <1% 28 $645.66
90685 <1% 133 $640.04
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 112 $635.68
36416 <1% 11,490 $629.32
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,432 $620.76
D0330 Panoramic radiographic image <1% 22 $619.00
93325 <1% 30 $606.87
87563 <1% 30 $578.82
88341 <1% 695 $574.69
90710 <1% 201 $548.26
90734 <1% 53 $532.03
81002 <1% 387 $529.50
A9270 Non-covered item or service <1% 72,036 $517.26
99406 <1% 288 $517.10
86200 <1% 61 $483.73
86308 <1% 99 $482.36
94375 <1% 32 $474.08
82977 <1% 15 $462.38
82150 <1% 110 $452.37
86694 <1% 20 $425.89
86695 <1% 33 $421.72
73090 <1% 389 $419.56
87280 <1% 41 $407.07
80320 <1% 4,498 $394.68
87046 <1% 159 $381.51
82040 <1% 41 $374.52
J3475 Injection, magnesium sulfate, per 500 mg <1% 5,159 $371.70
90460 Immunization administration through 18 years of age via any route, first or only component <1% 240 $344.47
90714 <1% 56 $330.79
83002 <1% 32 $328.65
86300 <1% 26 $328.54
J7050 Infusion, normal saline solution, 250 cc <1% 592 $325.69
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,833 $318.26
90656 <1% 139 $295.01
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 28,021 $291.05
93270 <1% 19 $285.70
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 16,235 $285.27
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 98 $271.02
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 1,275 $270.72
80349 <1% 115 $270.05
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 27,999 $264.15
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 33 $244.51
86334 <1% 20 $237.50
88184 <1% 42 $225.37
98926 <1% 110 $223.65
G0008 Administration of influenza virus vaccine <1% 2,544 $223.29
86160 <1% 20 $209.98
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 22 $207.09
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,660 $207.02
90681 <1% 51 $205.15
84480 <1% 15 $199.41
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 488 $194.50
87329 <1% 27 $193.85
87107 <1% 20 $186.03
82785 <1% 14 $170.78
J3010 Injection, fentanyl citrate, 0.1 mg <1% 12,391 $169.19
J0690 Injection, cefazolin sodium, 500 mg <1% 7,071 $166.92
94150 <1% 282 $158.07
76882 <1% 12 $155.84
90700 <1% 44 $152.66
83525 <1% 14 $141.72
88312 <1% 58 $127.44
J2704 Injection, propofol, 10 mg <1% 14,808 $123.63
99153 Mod sedat endo service >5yrs <1% 3,735 $123.56
0001A <1% 29 $114.48
83010 <1% 15 $106.34
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 10,503 $106.23
90461 <1% 171 $105.70
85347 <1% 39 $102.10
99188 <1% 14 $100.80
98925 <1% 17 $99.18
73552 <1% 104 $98.82
72050 <1% 38 $98.23
69209 <1% 21 $95.10
72052 <1% 93 $93.57
93271 <1% 14 $93.52
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 13,189 $91.81
88185 <1% 42 $89.13
80175 <1% 14 $87.23
J1650 Injection, enoxaparin sodium, 10 mg <1% 4,360 $85.16
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 36 $85.12
85651 <1% 24 $71.01
93041 <1% 13 $69.48
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 4,936 $67.52
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,203 $64.64
C1769 Guide wire <1% 3,165 $64.21
80361 <1% 26 $63.01
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 203 $59.00
84155 <1% 31 $53.59
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,354 $50.07
J1644 Injection, heparin sodium, per 1000 units <1% 4,541 $42.13
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 535 $39.96
94762 <1% 89 $39.66
86580 <1% 15 $32.08
90474 <1% 18 $26.36
90473 <1% 68 $26.36
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 7,982 $25.94
90662 <1% 481 $19.13
J3480 Injection, potassium chloride, per 2 meq <1% 1,745 $18.51
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 5,972 $15.67
80365 <1% 26 $14.94
J1815 Injection, insulin, per 5 units <1% 6,335 $13.88
J2785 Injection, regadenoson, 0.1 mg <1% 795 $12.43
J2060 Injection, lorazepam, 2 mg <1% 3,543 $11.92
82310 <1% 30 $10.49
A4648 Tissue marker, implantable, any type, each <1% 524 $10.24
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,063 $9.93
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 204 $9.27
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 1,066 $8.83
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 160 $8.82
90732 <1% 42 $8.39
J1170 Injection, hydromorphone, up to 4 mg <1% 7,970 $8.17
J3370 Injection, vancomycin hcl, 500 mg <1% 378 $4.33
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,403 $3.94
94760 <1% 452 $2.76
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,043 $1.47
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,152 $1.07
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 690 $0.92
J3360 Injection, diazepam, up to 5 mg <1% 329 $0.80
J1630 Injection, haloperidol, up to 5 mg <1% 621 $0.31
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 3,676 $0.19
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 278 $0.18
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,080 $0.04
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 528 $0.03
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 560 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 1,688 $0.00
J3490 Unclassified drugs 0% 1,105 $0.00
72170 0% 60 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 252 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 200 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 15 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 1,388 $0.00
C9399 Unclassified drugs or biologicals 0% 333 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 506 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 238 $0.00
D0603 0% 32 $0.00
D0120 Dental checkup, returning patient 0% 15 $0.00
G0009 Administration of pneumococcal vaccine 0% 369 $0.00
76377 0% 261 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 74 $0.00
J1805 Injection, esmolol hydrochloride, 10 mg 0% 30 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 26 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 139 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 229 $0.00
94761 0% 15 $0.00
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg 0% 208 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 251 $0.00
51798 0% 45 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 88 $0.00
99495 0% 38 $0.00
99459 0% 13 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 30 $0.00
C1781 Mesh (implantable) 0% 42 $0.00
82435 0% 27 $0.00
J9045 Injection, carboplatin, 50 mg 0% 19 $0.00
91307 0% 13 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 54 $0.00
Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg 0% 13 $0.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 0% 19 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 15 $0.00
73060 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 562 $0.00
S0164 Injection, pantoprazole sodium, 40 mg 0% 1,565 $0.00
93319 0% 83 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 268 $0.00
S0028 Injection, famotidine, 20 mg 0% 1,578 $0.00
J3489 Injection, zoledronic acid, 1 mg 0% 34 $0.00
83037 0% 99 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 514 $0.00
91312 0% 13 $0.00
G8990 Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals 0% 127 $0.00
A4358 Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each 0% 118 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 294 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 630 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 168 $0.00
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 0% 14 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 89 $0.00
69210 0% 23 $0.00
C1729 Catheter, drainage 0% 15 $0.00
84295 0% 27 $0.00
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing 0% 34 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 295 $0.00
82374 0% 27 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 14 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 183 $0.00
0124A 0% 15 $0.00
J2310 Injection, naloxone hydrochloride, per 1 mg 0% 14 $0.00
88173 0% 35 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 37 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCCULLOUGH, MICHAEL (CFO)
Same official

Other billing entities under MCCULLOUGH, MICHAEL

Full network →
ProviderLocationPaid
Ascension Se Wisconsin Hospital, INCMilwaukee, WI$94.32M
Ascension ST Francis Hospital, INCMilwaukee, WI$35.87M
Ascension Ne Wisconsin, INCAppleton, WI$19.89M
A.F.C. Transportation, INCFlagstaff, AZ$10.12M
Columbia ST. Mary's Hospital Milwaukee, INCMilwaukee, WI$9.82M
Ascension Wisconsin Laboratories, INCMilwaukee, WI$5.81M
Ascension Ne Wisconsin, INCOshkosh, WI$4.31M
Ascension Via Christi Hospitals Wichita INC.Wichita, KS$4.09M
Ascension Calumet Hospital, INCChilton, WI$3.78M
Columbia ST. Mary's Hospital Milwaukee INCMilwaukee, WI$769K
Sacred Heart Rehabilitation Institute, INC.Mequon, WI$603K
Mercy Medical Center of Oshkosh, INC.Oshkosh, WI$486K
Ascension Ne Wisconsin, INCAppleton, WI$343K
Columbia ST. Mary's Hospital Milwaukee, INCGlendale, WI$158K
Columbia ST. Mary's Hospital Milwaukee, INCMilwaukee, WI$140K
Ascension Ne Wisconsin, INCMenasha, WI$63K
Columbia ST. Mary's Hospital Milwaukee, INCMequon, WI$26K
Ascension Se Wisconsin Hospital, INCWauwatosa, WI$9K
Sacred Heart Rehabilitation Institute, INCMilwaukee, WI$6K
Ascension Wisconsin Surgery Center-Mount Pleasant LLCMount Pleasant, WI$5K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.